Biologics Market Size, Share, Trends and Forecast by Source, Product, Disease, Manufacturing, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3883

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biologics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Source
6.1 Microbial
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Mammalian
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product
7.1 Monoclonal Antibodies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Recombinant Proteins
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antisense, RNAi and Molecular Therapy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Disease
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Immunological Disorders
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiovascular Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hematological Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Manufacturing
9.1 Outsourced
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 In-House
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche Ltd
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 GlaxoSmithKline plc
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Biologics Market: Major Drivers and Challenges
Figure 2: Global: Biologics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Biologics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Biologics Market: Breakup by Source (in %), 2024
Figure 5: Global: Biologics Market: Breakup by Product (in %), 2024
Figure 6: Global: Biologics Market: Breakup by Disease (in %), 2024
Figure 7: Global: Biologics Market: Breakup by Manufacturing (in %), 2024
Figure 8: Global: Biologics Market: Breakup by Region (in %), 2024
Figure 9: Global: Biologics (Microbial) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Biologics (Microbial) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Biologics (Mammalian) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Biologics (Mammalian) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Biologics (Other Sources) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Biologics (Other Sources) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Biologics (Monoclonal Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Biologics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Biologics (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Biologics (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Biologics (Recombinant Proteins) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Biologics (Recombinant Proteins) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Biologics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Biologics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Biologics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Biologics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Biologics (Immunological Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Biologics (Immunological Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Biologics (Cardiovascular Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Biologics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Biologics (Hematological Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Biologics (Hematological Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Biologics (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Biologics (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Biologics (Outsourced) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Biologics (Outsourced) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Biologics (In-House) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Biologics (In-House) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: North America: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: North America: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: United States: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: United States: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Canada: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Canada: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Asia-Pacific: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Asia-Pacific: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: China: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: China: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Japan: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Japan: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: India: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: India: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: South Korea: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: South Korea: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Australia: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Australia: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Indonesia: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Indonesia: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Others: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Others: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Europe: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Europe: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Germany: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Germany: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: France: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: France: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: United Kingdom: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: United Kingdom: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Italy: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Italy: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Spain: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Spain: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Russia: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Russia: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Others: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Others: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Latin America: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Latin America: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Brazil: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Brazil: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Mexico: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Mexico: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Others: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Others: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Middle East and Africa: Biologics Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Middle East and Africa: Biologics Market: Breakup by Country (in %), 2024
Figure 87: Middle East and Africa: Biologics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Global: Biologics Industry: SWOT Analysis
Figure 89: Global: Biologics Industry: Value Chain Analysis
Figure 90: Global: Biologics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biologics Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Biologics Market Forecast: Breakup by Source (in Million USD), 2025-2033
Table 3: Global: Biologics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 4: Global: Biologics Market Forecast: Breakup by Disease (in Million USD), 2025-2033
Table 5: Global: Biologics Market Forecast: Breakup by Manufacturing (in Million USD), 2025-2033
Table 6: Global: Biologics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Biologics Market: Competitive Structure
Table 8: Global: Biologics Market: Key Players

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.